Skye Bioscience, Inc.

SKYE ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2025

Total Assets: $28.3M

Liabilities Breakdown FY2025

Total Liabilities: $8.3M